Dr Reddys Laboratories LtdRDY
Price (close)
$12.30
Market cap
$10.3B
P/E
—
Revenue (FY)
$325.5B
Net income
$56.5B
Dividend yield
0.67%
1-year total return
-12.5%
Net margin
17.4%
Revenue growth
16.6%
Debt / equity
0.02x
What Dr Reddys Laboratories Ltd does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $174.6B | $189.7B | $214.4B | $245.9B | $279.2B | $325.5B |
| Net income | $19.5B | $17.2B | $23.6B | $45.1B | $55.7B | $56.5B |
| Free cash flow | $25.0B | $26.0B | $13.4B | $47.6B | $29.0B | $18.9B |
More on RDY.
- Dr Reddys Laboratories Ltd summary
- Dr Reddys Laboratories Ltd financial statements
- Dr Reddys Laboratories Ltd key metrics
- Dr Reddys Laboratories Ltd health scores and style box
- Dr Reddys Laboratories Ltd earnings
- Dr Reddys Laboratories Ltd dividends
- Dr Reddys Laboratories Ltd valuation
- Dr Reddys Laboratories Ltd ownership and insiders
- Dr Reddys Laboratories Ltd peers
Figures from Dr Reddys Laboratories Ltd's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.